法布瑞氏症治療的全球市場 - 產業分析，規模，佔有率，成長，趨勢，2022年～2028年的預測

本報告提供全球法布瑞氏症治療市場相關調查，市場概要，以及各治療，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 法布瑞氏症治療-產業分析

• 簡介-市場動態
• 市場促進因素
• 市場阻礙因素
• 機會
• 產業趨勢
• 波特的五力分析
• 市場魅力分析

第4章 價值鏈分析

第5章 COVID-19爆發的影響分析

第6章 全球法布瑞氏症治療市場分析，各治療

• 各治療概要
• 履歷資料與預測資料
• 各治療分析
• 酵素補充療法的銷售額成果及預測銷售額，各地區
• 基因治療的銷售額成果及預測銷售額，各地區
• 含Agalsidase Alpha的製劑的銷售額成果及預測銷售額，各地區
• 止痛藥的銷售額成果及預測銷售額，各地區
• 抗痙攣藥的銷售額成果及預測銷售額，各地區
• NSAIDS的銷售額成果及預測銷售額，各地區

第7章 全球法布瑞氏症治療市場分析，各終端用戶

• 各終端用戶概要
• 履歷資料與預測資料
• 各終端用戶分析
• 醫院的銷售額成果及預測銷售額，各地區
• 診所的銷售額成果及預測銷售額，各地區

第8章 全球法布瑞氏症治療市場分析，各地區

• 各地區的預測
• 簡介
• 北美的銷售額分析
• 歐洲的銷售額分析
• 亞太地區的銷售額分析
• 南美的銷售額分析
• 中東、非洲的銷售額分析

第9章 法布瑞氏症治療企業的競爭情形

• 法布瑞氏症治療市場上競爭
• 夥伴關係/合作/契約
• 合併和收購
• 新產品的銷售
• 其他的開發

第10章 企業簡介

• 主要企業的市場佔有率分析
• 市場集中度
• Abbvie Inc.
• Amgen Inc.
• Bristol-Myers Squibb Company
• Genzyme Corporation
• GlaxoSmithKline Plc
• Ibio Inc. Inc.
• Some Of The Existing
• Merc &Co. Inc.
• Neuraltus Pharmaceuticals
• Novartis Pharmaceuticals
• Pfizer Inc.
• Sanofi-Aventis LLC
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd

Value Market Research deeply researched the Global Fabry Disease Treatment Market to foresee a significant growth in the industry over the upcoming years. The global fabry disease treatment market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global fabry disease treatment market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this fabry disease treatment market.

The next sections of the fabry disease treatment market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Treatment

Enzyme Replacement Therapy

Gene Therapy

Pharmaceutical Formulations Containing Agalsidase Alpha

Analgesics

Anticonvulsants

NSAIDS

By End-User

Hospitals

Clinics

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . FABRY DISEASE TREATMENT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Treatment
  • 3.7.2 Market Attractiveness Analysis By End-User
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 5.1. Impact Analysis of Covid-19 Outbreak
  • 5.1.1. Direct Impact on Production
  • 5.1.2. Supply Chain and Market Disruption
  • 5.1.3. Financial Impact on Firms and Financial Markets
• 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 5.3. Market: Pre V/S Post COVID-19
• 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
• 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL FABRY DISEASE TREATMENT MARKET ANALYSIS BY TREATMENT

• 6.1 Overview by Treatment
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Treatment
• 6.4 Enzyme Replacement Therapy Historic and Forecast Sales by Regions
• 6.6 Gene Therapy Historic and Forecast Sales by Regions
• 6.5 Pharmaceutical Formulations Containing Agalsidase Alpha Historic and Forecast Sales by Regions
• 6.7 Analgesics Historic and Forecast Sales by Regions
• 6.8 Anticonvulsants Historic and Forecast Sales by Regions
• 6.9 NSAIDS Historic and Forecast Sales by Regions

7 . GLOBAL FABRY DISEASE TREATMENT MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-User
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-User
• 7.4 Hospitals Historic and Forecast Sales by Regions
• 7.5 Clinics Historic and Forecast Sales by Regions

8 . GLOBAL FABRY DISEASE TREATMENT MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE FABRY DISEASE TREATMENT COMPANIES

• 9.1. Fabry Disease Treatment Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF FABRY DISEASE TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Abbvie Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Amgen Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Bristol-Myers Squibb Company
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Genzyme Corporation
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. GlaxoSmithKline Plc
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Ibio Inc. Inc.
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Some Of The Existing
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Merc & Co. Inc.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Neuraltus Pharmaceuticals
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Novartis Pharmaceuticals
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Pfizer Inc.
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments
• 10.14. Sanofi-Aventis LLC
  • 10.14.1. Company Overview
  • 10.14.2. Company Revenue
  • 10.14.3. Products
  • 10.14.4. Recent Developments
• 10.15. Takeda Pharmaceutical Co. Ltd.
  • 10.15.1. Company Overview
  • 10.15.2. Company Revenue
  • 10.15.3. Products
  • 10.15.4. Recent Developments
• 10.16. Teva Pharmaceutical Industries Ltd
  • 10.16.1. Company Overview
  • 10.16.2. Company Revenue
  • 10.16.3. Products
  • 10.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• COVID-19 Impact Analysis by Production, Import, Export and Demand
• Pre V/S Post COVID-19
• Estimated Impact Of The Coronavirus (Covid-19) Epidemic
• COVID-19: Micro and Macro Factor Analysis
• Analysis by Treatment (USD MN)
• Enzyme Replacement Therapy Market Sales by Geography (USD MN)
• Gene Therapy Market Sales by Geography (USD MN)
• Pharmaceutical Formulations Containing Agalsidase Alpha Market Sales by Geography (USD MN)
• Analgesics Market Sales by Geography (USD MN)
• Anticonvulsants Market Sales by Geography (USD MN)
• NSAIDS Market Sales by Geography (USD MN)
• Analysis Market by End-User (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Clinics Market Sales by Geography (USD MN)
• Global Fabry Disease Treatment Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Fabry Disease Treatment Report
• Market Research Process
• Market Research Methodology
• Global Fabry Disease Treatment Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Treatment
• Market Attractiveness Analysis by End-User
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Treatment (USD MN)
• Enzyme Replacement Therapy Market Sales by Geography (USD MN)
• Gene Therapy Market Sales by Geography (USD MN)
• Pharmaceutical Formulations Containing Agalsidase Alpha Market Sales by Geography (USD MN)
• Analgesics Market Sales by Geography (USD MN)
• Anticonvulsants Market Sales by Geography (USD MN)
• NSAIDS Market Sales by Geography (USD MN)
• Global Market Analysis by End-User (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Clinics Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.